News | Hemodynamic Support Devices | September 20, 2018

Abiomed Showcases Expanded FDA Indications, Next-Generation Heart Recovery Products at TCT 2018

Company will feature cath lab experience and demonstrations, presentations on Protected PCI and cardiogenic shock

Abiomed Showcases Expanded FDA Indications, Next-Generation Heart Recovery Products at TCT 2018

September 19, 2018 — Abiomed Inc. announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (TCT) conference will highlight the recently expanded U.S. Food and Drug Administration (FDA) indications for high-risk percutaneous coronary intervention (PCI) and cardiogenic shock. Initiatives will also highlight Protected PCI’s ability to allow for more complete revascularization, which improves outcomes1 and quality of life2,3. More than 30 presentations as well as live cases featuring Impella heart pumps are expected at TCT 2018, taking place Sept. 21-25 in San Diego, California.

New for TCT 2018, Abiomed’s booth will feature a cath lab experience with demonstrations and simulations of advancements including:

  • Abiomed’s augmented reality simulator which provides hands-on experience with the Impella RP and the newly FDA approved Impella CP with SmartAssist, which includes hemodynamic sensors to intelligently position and manage the device;
  • Simulations of Impella CP with SmartAssist’s real-time informational displays of new hemodynamic metrics; and
  • Live demonstrations of Abiomed’s latest innovation, Impella Connect, which provides real-time information in the cloud to connect remote support resources.

In the hemodynamic support and patient management pavilion, Abiomed is hosting practical, hands-on workshops on large bore access and closure, advanced hemodynamics, best practices in cardiogenic shock and complex Protected PCI strategies.

Watch the VIDEO Cardiogenic Shock Supported With Impella Shows Good Outcomes

A breakfast symposium on Saturday, Sept. 22 at 6:30 a.m. will feature data on Abiomed’s FDA approval for cardiogenic shock associated with cardiomyopathy, including peripartum and postpartum cardiomyopathy. Faculty will also discuss the role of ventricular unloading and the latest results from the National Cardiogenic Shock Initiative (NCSI). Initial NCSI data showed 76 percent survival and 100 percent native heart recovery when the NCSI protocol and best practices were used.

Watch the VIDEO Overview of the National Cardiogenic Shock Initiative

Protected PCI with Impella allows for more complete revascularization, which improves outcomes and quality of life. Abiomed anticipates the broadcast of several elective high-risk PCI live cases using hemodynamic support with the Impella heart pump.

The schedule for Protected PCI and cardiogenic shock related TCT symposia is included below.

Saturday, Sept. 22

Co-sponsored Symposium:New Treatment Strategies for Cardiogenic Shock: Impella Expanded Indications

6:30–8:00 a.m. | Room 23 B-C

  • Cindy Grines, M.D.: Advances in the Treatment of Cardiovascular Disease in Women: PCI, MI, Shock, Myocarditis, SCAD and Post-partum Cardiomyopathy
  • William O’Neill, M.D.: The Impact of The Cardiogenic Shock Initiative (NCSI): One Year Later
  • Navin Kapur, M.D.: Understanding the Importance of Ventricular Unloading in Management of AMI and Cardiogenic Shock


Presentation Theater Program: Contrast-Induced Acute Kidney Injury – Preventive Measures That Work

Saturday, Sept. 22 | 11:30 a.m.–12:30 p.m.

San Diego Convention Center, Presentation Theater 2, Hall B2, Ground Level

CHIP Angiogram Review: What’s New with Focused Case Presentations

Saturday, Sept. 22 | 6:30–8:00 p.m.

Marriott Marquis San Diego Marina, Pacific Ballroom 18-19

Sunday, Sept. 23

Co-sponsored Symposium: Management of Complex PCI Patients: Award-winning Case Presentations

6:30–8:00 a.m. | Room 23 B-C

Chair: David Wohns, M.D.

Faculty: Amir Kaki, M.D.; George Vetrovec, M.D.

Interactive Training Pavilion: Hemodynamic Support & Patient Management

Saturday, Sept. 22 and Sunday, Sept. 23

  • Large Bore Access & Closure
    • Faculty: Amir Kaki, M.D.; James McCabe, M.D.; Raj Tayal, M.D.
  • Cardiogenic Shock (NCSI)
    • Faculty: Navin Kapur, M.D.; William O’Neill, M.D.; Brian Porvin, M.D.
  • TEACH Intro
    • Faculty: Dan Burkoff, M.D.; Reshad Garan, M.D.; John Lasala, M.D.; Salvatore Mannino, M.D.; Perwaiz Meraj, M.D.; Lynn Morris, M.D.; Raj Patel, M.D.; Brian Porvin, M.D.
  • Complex Protected PCI
    • Faculty: Hiram Bezerra, M.D.; Dan Burkoff, M.D.; Mauricio Cohen, M.D.; Colin Hirst, M.D.; Paul Mahoney, M.D.; Duane Pinto, M.D.; Uma Rangasetty, M.D.; Adhir Shroff, M.D.

For more information:

Related Content

VIDEO: Hemodynamic Support Protocols at Henry Ford Hospital


  1. Dangas, G. et al. Am. Journ of Cardiol. 2014 Jan 15;113(2):222-8.
  2. Abiomed data on file.
  3. O'Neill, W. et al. Circulation. 2012 Oct 2;126(14):1717-27.

Related Content

Videos | TCT | October 03, 2018
DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technology he found on the ex
cardiologist Ted Feldman, M.D., at TCT 2017. #TCT2018 #TCT #TCT18 TCT Late breaking trials, studies.
Feature | TCT | September 21, 2018
October 4, 2018 – The Cardiovascular Research Foundation (CRF) had 15 late-breaking trials and 12 late-breaking clini
Interventional cardiology, cath lab technology, TCT, transcatheter cardiovascular therapeutics. #TCT #TCT18 #TCT2018
Feature | TCT | September 14, 2018 | Dave Fornell, Editor
The volume of information attendees receive at the annual...
Videos | TCT | November 15, 2017
DAIC Editor Dave Fornell shows some of the innovations displayed on the expo floor at the 2017 Transcatheter Cardiova
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | TCT | November 09, 2017
November 9, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has select
Key Interventional Cardiology and structural heart Technologies to Prepare for TCT 2017.
Feature | TCT | October 26, 2017 | Dave Fornell
Here is an aggregation of DAIC content for all major cardiovascular technology news and advances this past year. These...
Videos | TCT | November 18, 2016
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology technologies
Videos | TCT | November 05, 2015
DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies pr
Videos | TCT | November 05, 2015
Tom Watson, clinical analyst for MDBuyLine, and DAIC Dave Fornell discuss some of the technology trends at the 2015 T
Amaranth Fortitute Bioresorbable stent

The Amaranth Fortitute bioresorbable stent was among several fully bioresorbing platforms discussed in sessions, late breaking trial data presentations and on the expo floor at TCT 2015.

Feature | TCT | October 19, 2015 | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline
There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) ann
Overlay Init